ask="7.20"
ask_size="700"
average_daily_volume="41069"
bid="4.02"
bid_size="200"
book_value="5.08"
change="-0.08"
change_from_200_day_moving_average="-1.63"
change_from_50_day_moving_average="-1.04"
change_from_52_week_high="-8.73"
change_From_52_week_low="0.13"
change_in_percent="-1.94%"
close="4.02"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-3.06"
ebitda="-20.26M"
eps_estimate_current_year="-8.61"
eps_estimate_next_quarter="-0.80"
eps_estimate_next_year="-2.57"
ex_dividend_date="N/A"
float_shares="6404000"
high="4.41"
high_52_weeks="12.75"
last_trade_date="1/27/2017"
last_trade_price="4.02"
last_trade_size="203"
last_trade_time="4:00pm"
low="4.00"
low_52_weeks="3.89"
market_capitalization="53.99M"
moving_average_200_day="5.65"
moving_average_50_day="5.06"
name="Aeglea BioTherapeutics
Inc."
notes="N/A"
one_year_target_price="17.00"
open="4.25"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-28.88%"
percent_change_from_50_day_moving_average="-20.51%"
percent_change_from_52_week_high="-68.47%"
percent_change_from_52_week_low="+3.34%"
previous_close="4.10"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="0.81"
price_per_sales="11.09"
revenue="4.97M"
shares_outstanding="13430000"
short_ratio="0.55"
stock_exchange="NGM"
symbol="AGLE"
volume="183559"
weeks_range_52="3.89 - 12.75"
